LPTX News and Press, Leap Therapeutics Inc. From 01/16/24

Leap Therapeutics to Present New Clinical Data from Part A of DeFianCe Study at the 2024 ASCO Gastrointestinal Cancers Symposium PR Newswire 30% ORR and 93% DCR across heterogenous second-line CRC patients treated with DKN-01 plus bevacizumab and chemotherapy ...

Leap Therapeutics to Participate at the 42nd Annual J.P. Morgan Healthcare Conference PR Newswire CAMBRIDGE, Mass. , Jan. 3, 2024 /PRNewswire/ -- Leap Therapeutics, Inc. (Nasdaq:LPTX), a biotechnology company focused on developing targeted and immuno-oncolog...

Leap Therapeutics Announces Completion of Enrollment in Randomized Controlled Part C of the DisTinGuish Study of DKN-01 for the Treatment of Gastric Cancer Patients PR Newswire CAMBRIDGE, Mass. , Jan. 2, 2024 /PRNewswire/ -- Leap Therapeutics, Inc. (Nasdaq:LPTX)...

Leap Therapeutics to Present New Data from Part A of the DeFianCe Study of DKN-01 Plus Bevacizumab and Chemotherapy in Colorectal Cancer Patients at the 2024 ASCO Gastrointestinal Cancers Symposium PR Newswire CAMBRIDGE, Mass. , Dec. 11, 2023 /PRNewswire/ -- Leap...

2023-11-24 11:20:37 ET More on Mid-day movers stock. Breaking: Bitcoin ETFs On The Verge Of Approval; Position For The Crypto Moon With Bakkt Bakkt Holdings, Inc. 2023 Q3 - Results - Earnings Call Presentation Bakkt Holdings, Inc. (BKKT) Q3 2023 Earnings Call Transcr...

2023-11-22 12:37:58 ET DENVER, Colo., Nov. 22, 2023 ( www.247marketnews.com )- The following companies published announcements or are trading higher on higher-than-usual midday volume; SciSparc Ltd (NASDAQ: SPRC), PaxMedica Inc (NASDAQ: PXMD), MoneyHero Ltd (NASDAQ: MNY), Jumia Technolo...

Leap Therapeutics to Participate at Piper Sandler 35th Annual Healthcare Conference PR Newswire CAMBRIDGE, Mass. , Nov. 21, 2023 /PRNewswire/ -- Leap Therapeutics, Inc. (Nasdaq:LPTX), a biotechnology company focused on developing targeted and immuno-oncology ther...

2023-11-13 07:21:47 ET More on Leap Therapeutics Seeking Alpha’s Quant Rating on Leap Therapeutics Historical earnings data for Leap Therapeutics Financial information for Leap Therapeutics For further details see: Leap Therapeutics GAAP EPS of -$0...

Leap Therapeutics Reports Third Quarter 2023 Financial Results PR Newswire CAMBRIDGE, Mass. , Nov. 13, 2023 /PRNewswire/ -- Leap Therapeutics, Inc. (Nasdaq:LPTX), a biotechnology company focused on developing targeted and immuno-oncology therapeutics, today ...

INVO BioScience Inc. (INVO) is expected to report for Q3 2023 HIVE Blockchain Technologies Ltd (HIVE) is expected to report $-0.13 for Q2 2024 BioNexus Gene Lab Corp (BGLC) is expected to report for Q1 2024 Adhera Therapeutics Inc (ATRX) is expected to report for Q1 2024 Altus Pow...